|
|
Volumn 32, Issue 5, 2007, Pages 593-
|
|
Adalimumab vs. etanercept in psoriasis [12]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ADALIMUMAB;
BETAMETHASONE DIPROPIONATE PLUS CALCIPOTRIOL;
CALCIPOTRIOL;
CYCLOSPORIN A;
ETANERCEPT;
INFLIXIMAB;
METHOTREXATE;
CLINICAL PRACTICE;
COMBINATION CHEMOTHERAPY;
DRUG EFFICACY;
DRUG SAFETY;
DRUG USE;
HUMAN;
LETTER;
MONOTHERAPY;
PRIORITY JOURNAL;
PSORIASIS;
PUSTULOSIS PALMOPLANTARIS;
RHEUMATOID ARTHRITIS;
TREATMENT OUTCOME;
ANTI-INFLAMMATORY AGENTS;
ANTIBODIES, MONOCLONAL;
DERMATOLOGIC AGENTS;
DRUG THERAPY, COMBINATION;
HUMANS;
IMMUNOGLOBULIN G;
IMMUNOSUPPRESSIVE AGENTS;
PSORIASIS;
RECEPTORS, TUMOR NECROSIS FACTOR;
|
|
EID: 34547809363
PISSN: 03076938
EISSN: 13652230
Source Type: Journal
DOI: 10.1111/j.1365-2230.2007.02494.x Document Type: Letter |
|
Times cited : (2)
|
|
References (1)
|
